Cite
APA Citation
Hartmann, S., Zwick, L., Maurus, K., Fuchs, A. R., Brands, R. C., Seher, A., Kübler, A. C., & Müller-Richter, U. D. (2018). melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer. Journal of cranio-maxillofacial surgery, 46(3), 492–497. http://access.bl.uk/ark:/81055/vdc_100057145074.0x000013